"You Can Lead a Horse to Water, but You Can't Make It Drink". Gastroenterology Healthcare Professionals' Perceptions of Reasons for Patient Non-Adherence to Inflammatory Bowel Disease Prescribed Medication: A Qualitative Study.

Key Takeaways for GI Nurses

• Healthcare providers' perceptions of medication non-adherence may not align with patients' actual barriers, highlighting the need for improved patient-provider communication during pre-procedure assessments and follow-up care
• Understanding the gap between clinical assumptions and patient realities can help nurses develop more effective patient education strategies and adherence support programs in GI practice settings
• This research underscores the importance of exploring patient perspectives directly rather than relying solely on provider assumptions when addressing medication compliance issues
• GI nurses are uniquely positioned to bridge communication gaps between patients and physicians by conducting thorough medication reconciliation and adherence assessments during patient encounters

Clinical Relevance

This qualitative study provides valuable insights into the disconnect between healthcare providers' assumptions about IBD medication non-adherence and the actual patient experience. For GI nurses, this research highlights a critical opportunity to enhance patient care through more targeted communication strategies. During pre-procedure consultations, medication reconciliation, and patient education sessions, nurses can use these findings to ask more specific, open-ended questions about medication challenges rather than making assumptions about why patients may not be taking their prescribed therapies as directed.

The study's focus on provider perceptions also has implications for interdisciplinary collaboration within GI units. Nurses often serve as the primary point of contact for patients experiencing medication-related concerns, making them ideally positioned to gather authentic patient feedback about adherence barriers. This information can then be effectively communicated to gastroenterologists and other team members to develop more patient-centered treatment approaches. Understanding the provider perspective can help nurses advocate more effectively for their patients by addressing misconceptions and ensuring that clinical decisions are based on accurate assessments of patient needs and circumstances.

From a quality improvement standpoint, these findings suggest that GI units may benefit from implementing more structured approaches to adherence assessment and support. Nurses can lead initiatives to develop standardized tools and protocols that capture patient-reported barriers to medication adherence, moving beyond traditional compliance monitoring to address the root causes of non-adherence in IBD patients.

Bottom Line

This research reveals important gaps between what healthcare providers think drives IBD medication non-adherence and what patients actually experience, presenting GI nurses with a significant opportunity to improve patient outcomes through enhanced communication, more accurate adherence assessments, and patient-centered education strategies that address real rather than perceived barriers to medication compliance.